Navigation Links
Taligen Therapeutics Initiates Corporate Growth Plan with Appointment of Abbie Celniker, Ph.D., as CEO and Establishment of Cambridge, Mass., Headquarters
Date:7/23/2008

aligen at a time the company is moving rapidly toward the clinical development stage," said Tim Mills, Ph.D., Taligen's chairman and a managing director with Sanderling Ventures. "I look forward to working with her as we implement our corporate growth plan to build a company focused on the development of a pipeline of protein therapeutics intended for the treatment of diseases where complement dysregulation is implicated."

In January Taligen closed the first tranche of a $65 million Series B financing led by Alta Partners and Clarus Ventures with participation from existing investors Sanderling Ventures, Tango and High Country Venture. The financing is expected to enable Taligen to implement its growth plan and advance multiple product candidates to the proof-of-concept stage.

"I am thrilled to join and lead the Taligen team," said Dr. Celniker. "The complement system is emerging as a critical area for drug development. Taligen's founders discovered and validated the importance of the alternative pathway as an amplification loop in the inflammation process. Based on this expertise, the company has designed protein therapeutics that are intended for the treatment of a wide range of orphan and large indications. These programs are cutting-edge and should be very appealing to prospective corporate partners. With the company's expertise, protein therapeutic development candidates and strong financial backing, Taligen is well-positioned to implement its corporate growth plan."

About Taligen Therapeutics

Taligen Therapeutics is focused on the discovery and development of novel protein therapeutics that are designed to modulate the alternative pathway of the complement system to treat a wide range of inflammatory conditions and diseases. The company's lead therapeutic candidates are monoclonal antibodies and recombinant fusion proteins that target key factors in the alternative pathway, which Taligen's founders have validated as an important amp
'/>"/>

SOURCE Taligen Therapeutics Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinsons Therapeutics
2. Hyperion Therapeutics Completes Enrollment in Phase 1/2 Clinical Trial in Patients With Urea Cycle Disorders
3. Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models
4. Paper in Molecular Cancer Therapeutics Reports that a Novel Combination of Alfacells ONCONASE(R) and Rosiglitazone Induces a Synergistic Apoptotic Effect in Several Cancer Cell Lines
5. Velcura Therapeutics, Inc. Adds William Brinkerhoff to its Board of Directors
6. PTC Therapeutics Announces $25 Million Award From Cystic Fibrosis Foundation Therapeutics for Development of PTC124
7. Echo Therapeutics Announces Publication of Positive Clinical Data for its Symphony Transdermal Continuous Glucose Monitoring System in Journal of Diabetes Science and Technology
8. Nile Therapeutics Announces Dosing in Phase IIa Study of CD-NP in Heart Failure Patients
9. Echo Therapeutics Initiates Clinical Study of Its Symphony(TM) Transdermal Continuous Glucose Monitoring System in Patients with Type 1 and Type 2 Diabetes
10. Silence Therapeutics Announces Board Changes
11. Halozyme Therapeutics Announces That Chemophase Meets Primary Endpoint in Phase I/IIa Clinical Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2015)... -- bioMérieux, a world leader in the field of ... the White House Forum on Antibiotic Stewardship for the ... means to address antibiotic resistance. Over 150 major experts ... to discuss the possible ways to implement changes over ... antibiotic-resistant bacteria, and prevent the spread of resistant infections ...
(Date:6/1/2015)... , June 1, 2015 Select Medical ... MJ Acquisition Corporation, a joint venture that Select Medical ... L.P., has completed its previously announced acquisition of Concentra ... new joint venture. About Select Medical ... of specialty hospitals and outpatient rehabilitation clinics in ...
(Date:6/1/2015)... June 1, 2015   Royal Philips  (NYSE: PHG, ... Resonance (MR) solutions to be showcased at the ... 23 rd Annual Meeting & Exhibition in ... booth #301 will see the latest in innovations ... clinical performance, enhance patient experience and provide economic value. ...
Breaking Medicine Technology:bioMerieux Honored to Participate in the White House Forum on Antibiotic Stewardship 2bioMerieux Honored to Participate in the White House Forum on Antibiotic Stewardship 3Select Medical Holdings Corporation Announces Completion of Acquisition of Concentra Inc. through Joint Venture with Welsh Carson 2Select Medical Holdings Corporation Announces Completion of Acquisition of Concentra Inc. through Joint Venture with Welsh Carson 3Philips showcases MR research solutions designed to enable collaboration with partners at the ISMRM Annual Meeting 2Philips showcases MR research solutions designed to enable collaboration with partners at the ISMRM Annual Meeting 3
... SAN DIEGO, Aug. 16, 2011 Optimer Pharmaceuticals, Inc. ... subgroup analysis of patients receiving concomitant systemic antibiotics in ... DIFICID™ (fidaxomicin) tablets in the treatment of adult patients ... online in the September 1 issue of Clinical ...
... 16, 2011 CVS/pharmacy announced today that all ... Compliance Corp.,s Environmental Return System, which provides customers ... unused, expired or unwanted drugs using affordable medication ... The postage-paid envelopes cost $3.99 and allow customers ...
Cached Medicine Technology:Clinical Infectious Diseases Publishes Subgroup Analysis Showing Optimer's DIFICID™ (fidaxomicin) Tablets Exhibited Higher Clinical Cure and Global Cure Rates Than Vancomycin in Patients with Clostridium difficile-Associated Diarrhea (CDAD) Receivin 2Clinical Infectious Diseases Publishes Subgroup Analysis Showing Optimer's DIFICID™ (fidaxomicin) Tablets Exhibited Higher Clinical Cure and Global Cure Rates Than Vancomycin in Patients with Clostridium difficile-Associated Diarrhea (CDAD) Receivin 3Clinical Infectious Diseases Publishes Subgroup Analysis Showing Optimer's DIFICID™ (fidaxomicin) Tablets Exhibited Higher Clinical Cure and Global Cure Rates Than Vancomycin in Patients with Clostridium difficile-Associated Diarrhea (CDAD) Receivin 4Clinical Infectious Diseases Publishes Subgroup Analysis Showing Optimer's DIFICID™ (fidaxomicin) Tablets Exhibited Higher Clinical Cure and Global Cure Rates Than Vancomycin in Patients with Clostridium difficile-Associated Diarrhea (CDAD) Receivin 5Clinical Infectious Diseases Publishes Subgroup Analysis Showing Optimer's DIFICID™ (fidaxomicin) Tablets Exhibited Higher Clinical Cure and Global Cure Rates Than Vancomycin in Patients with Clostridium difficile-Associated Diarrhea (CDAD) Receivin 6CVS/pharmacy Offers Customers Safe Disposal Program for Medications 2CVS/pharmacy Offers Customers Safe Disposal Program for Medications 3
(Date:6/1/2015)... Unlike most generator rental companies, which raise their rates ... to when the generator is in standby mode, WPP charges ... generator or not. WPP also offers an offsite storage option ... a few hours — for companies that do not have ... , “Even minor business disruptions are very expensive for commercial ...
(Date:6/1/2015)... June 01, 2015 Rio Salado College’s ... children and young adults this summer. , The clinics take ... a.m. to 3 p.m. at the Rio Salado Dental Clinic. ... Tempe. , “A big goal for us is to offer ... for our students,” said Nikki Shipp, Clinical Coordinator for Rio’s ...
(Date:6/1/2015)... June 01, 2015 Cambia Health ... today a new, interactive Affordable Care Act (ACA) ... The course, called “Affordable Care Act Expert Series, ... the strategic and consultative insights necessary to effectively ... navigate the impacts of the ACA. , The ...
(Date:6/1/2015)... 01, 2015 KC and Monica Craichy, ... of the best superfood products in the ... in Texas. , "Monica and I are excited ... in distributing Living Fuel Super Meals - SuperBerry®, SuperGreens ... floods in Texas," KC Craichy said. "We have attempted ...
(Date:6/1/2015)... 01, 2015 Northridge dentist , ... offering patients a promotion on Invisalign for a limited ... treatment is reduced to $3,700. Patients can find out ... consultation and discuss the extent of correction they need. ... be combined with any other offer. , Invisalign ...
Breaking Medicine News(10 mins):Health News:Worldwide Power Products Offers “Budget Billing” Contingency Generator Rental Program; Guarantees Power for Peak of Hurricane Season and Beyond 2Health News:Kids Receive Complimentary Dental Services at Rio Salado Dental Clinic 2Health News:Cambia Partners with AHIP to Offer Expert Series ACA Training Course 2Health News:Cambia Partners with AHIP to Offer Expert Series ACA Training Course 3Health News:Nearly $100,000 In Emergency Food Aid to Flood Victims in Texas Provided by Living Fuel and Natural News 2Health News:Nearly $100,000 In Emergency Food Aid to Flood Victims in Texas Provided by Living Fuel and Natural News 3Health News:Northridge Dentists, Drs. Michel Elyson and Ramin Assili, are Now Offering a Limited Time Promotion on Invisalign 2
... PAUL, Minn., July 3 The Minnesota Nurses,Association (MNA) ... for U.S. House of Representatives, Congressional District 2., ... will be the vigorous and,informed advocate we need in ... said MNA Political Committee Chair, Tom Kelly, RN.,"With his ...
... Previous measures aimed at adults, but Australian team says these ... -- A series of tests that are the first to ... developed by Australian researchers. , Using these three tests ... the Odor Identification Test -- the researchers determined that most ...
... National and regional healthcare,leaders will convene in Mendocino ... Improve Patient Care in 2008.", "Ultimately we want ... electronic medical record software and by enabling the exchange,of ... president of Redwood MedNet, the conference host., The ...
... of disease in developing countries, study suggests, , , THURSDAY, ... where breast-feeding is a necessity, and HIV is rampant, ... be reduced if infants were first fed a freeze-dried ... potentially destroy the deadly virus. , But that hope ...
... in a historical,and unprecedented move, the Pennsylvania legislature ... 1150 to mandate commercial,insurance companies to cover some ... House Speaker Dennis M. O,Brien, requires insurance,companies to ... less than 21 years old., In nearly ...
... July 3 Dangerous air pollution,resulting from wildfires ... in the surrounding areas. Residents with respiratory problems ... with chronic heart,disease should take extra precautions during ... develop., "Even those without lung diseases are ...
Cached Medicine News:Health News:Minnesota Nurses Association Endorses Steve Sarvi for Congress 2Health News:Improving Healthcare in Rural Northern California Goal of One-Day Conference of National and State Healthcare Leaders 2Health News:Freeze-Dried Formula May Block HIV Virus in Breast Milk 2Health News:Pennsylvania Tells Autism Speaks to Stop Talking 2Health News:American Lung Association Urges People Living Near Wildfires to Protect Themselves Against Staggering Levels of Unhealthy Air Pollution 2Health News:American Lung Association Urges People Living Near Wildfires to Protect Themselves Against Staggering Levels of Unhealthy Air Pollution 3
CCR Medical fiberoptic green system laryngoscope handles., ,OUTSTANDING PERFORMANCE, QUALITY, AND PRICING MAKE OUR FIBEROPTIC SELECTION MOST ECONOMICAL....
CCR Medical conventional laryngoscopes....
CCR Medical conventional laryngoscopes....
... ,Launched in 1988, this design revolutionized ... standard practice in general anesthesia. Used successfully ... Classic™ is a safe hands free alternative ... Classic™ can be used for a wide ...
Medicine Products: